Tesa peptide is a tesamorelin-based GH secretagogue, often blended with ipamorelin. Learn how tesa/IPA works, typical doses, side effects, and safety.
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog, and it is the compound people mean when they say "tesa peptide." It is FDA-approved under the brand name Egrifta for one narrow purpose: reducing excess abdominal visceral fat in adults with HIV-associated lipodystrophy. Outside that indication, "tesa" usually refers to a research blend of tesamorelin and ipamorelin, commonly sold as a tesa/IPA peptide.
What Is Tesa Peptide?
Tesamorelin is a 44-amino-acid peptide that mimics the body's own GHRH. It binds to GHRH receptors in the pituitary gland and signals it to release more growth hormone, which then raises IGF-1 levels.
Unlike direct growth hormone injections, tesamorelin works upstream. The pituitary still controls the release, but the signal is amplified — which is why it is classified as a growth hormone secretagogue rather than a hormone replacement.
- Class: GHRH analog (growth hormone-releasing hormone)
- Brand name: Egrifta WR (tesamorelin for injection)
- FDA status: Approved only for HIV-associated lipodystrophy
- Route: Subcutaneous injection
People often ask what is a tesa injection, and the answer is simple: it is a reconstituted lyophilized powder drawn into an insulin syringe and injected under the skin, usually in the abdomen.
What Is the Tesa and IPA Stack?
A tesa and IPA stack pairs tesamorelin with ipamorelin, a five-amino-acid ghrelin mimetic. The two act on different receptors — GHRH receptors and the ghrelin/GHS-R1a receptor — which is why they are frequently discussed together.
For a deeper look at the second half of the blend, a dedicated guide on what is ipamorelin peptide explains how selective ghrelin mimetics trigger growth hormone pulses with relatively little effect on cortisol or prolactin.
Blends are sold as lyophilized powder in vials, usually at ratios such as 5 mg tesa / 5 mg ipa or 10 mg / 5 mg. These are research chemicals, not finished pharmaceutical products.
| Compound | Receptor target | Typical research dose | FDA-approved for human use? |
|---|---|---|---|
| Tesamorelin | GHRH receptor | 2 mg SC once daily (approved dose) | Yes — HIV lipodystrophy only |
| Ipamorelin | Ghrelin / GHS-R1a | 100–300 mcg SC, 2–3x daily in research settings | No |
| Tesa/IPA blend | Both receptors | Varies by vial ratio | No |
What Is Tesa Peptide Used For?
The only FDA-approved use of tesamorelin is reducing visceral adipose tissue in HIV-positive adults with lipodystrophy, a condition in which fat redistributes to the abdomen and neck.
Clinical trials showed meaningful reductions in visceral fat, and some reported improvements in triglycerides and liver fat. Those results come from a specific patient population, so they do not automatically translate to general weight loss or body composition in healthy adults.
If you are wondering what is tesa peptide used for in everyday practice, the honest answer is: visceral fat reduction in a defined clinical group, plus a large amount of off-label experimentation with very little supporting data.
People who buy aod-9604 peptide for fat-loss research often compare it with tesamorelin, because both are studied for their effects on adipose tissue — but they work through completely different mechanisms.
Tesa Peptide Dosage and Injection Basics
The approved tesamorelin dose is 2 mg injected subcutaneously once daily. Reconstituted vials are typically refrigerated and used within a set window.
Because blend ratios vary, most researchers use a peptide dosing calculator to convert milligrams of powder and milliliters of bacteriostatic water into micrograms per unit on an insulin syringe. Getting that math wrong is one of the most common dosing errors.
- Reconstitute with bacteriostatic water, adding it slowly down the vial wall.
- Swirl, never shake, until the powder fully dissolves.
- Inject subcutaneously into the abdomen and rotate sites.
- Record the reconstitution date and follow the storage guidance on the vial.
Timing matters in the research literature. GHRH analogs are usually discussed as an evening dose, when natural growth hormone release peaks.
Side Effects and Safety Concerns
Tesamorelin's label carries real warnings. The most common side effects reported in trials were injection-site reactions, joint pain, and peripheral edema.
More importantly, tesamorelin raises IGF-1, and elevated IGF-1 is a theoretical concern for tumor growth. It can also affect blood sugar control, so people with diabetes or prediabetes need medical supervision.
Tesamorelin is not recommended during pregnancy, and it should not be used by anyone with active malignancy or a history of pituitary disease without a doctor's clearance.
Ipamorelin has a milder reported side-effect profile in early studies, but the tesa/IPA blend has never been tested as a combination in controlled human trials. Its risk profile is essentially unknown.
It is also frequently discussed alongside unrelated compounds, which is why searches like what is semax peptide used for show up next to tesamorelin queries — the research peptide category is broad, and not every compound works the same way.
Is Tesa Peptide Legal? FDA Status and Buying Risks
Tesamorelin is a prescription drug in the United States. As Egrifta, it is available only with a prescription for its approved indication.
Research-grade tesamorelin and tesa/IPA blends sold online are a different category. They are labeled "not for human consumption," and the FDA has repeatedly warned that these products may be mislabeled, underdosed, or contaminated.
There is no legal pathway for a consumer to buy tesa peptide for personal use. Anyone considering it should talk with a licensed healthcare professional instead of self-prescribing from a research chemical vendor.
Bottom Line
Tesamorelin is an FDA-approved drug for one narrow condition, and it is widely misunderstood online as a general fat-loss or anti-aging peptide. The tesa/IPA blend is a research-chemical combination with no approved human use and no controlled combination data.
If you have questions about growth hormone secretagogues and your own health, bring them to a physician or endocrinologist rather than a product page.
Frequently Asked Questions
What is tesa peptide used for?
Tesamorelin, the active peptide in tesa products, is FDA-approved to reduce excess abdominal visceral fat in adults with HIV-associated lipodystrophy. It is not approved for general weight loss, anti-aging, or athletic performance, and evidence in healthy adults is limited.
Is tesa peptide the same as tesamorelin?
Yes. "Tesa" is shorthand for tesamorelin, a synthetic 44-amino-acid GHRH analog sold as Egrifta. In a tesa/IPA blend, tesamorelin is combined with ipamorelin, a separate ghrelin-mimetic peptide that acts on a different receptor.
Is tesa peptide legal in the United States?
Tesamorelin is a prescription medication in the US and is legal only with a valid prescription for its approved indication. Research-grade tesa peptide sold online is labeled not for human consumption and is not a legal consumer product.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.